Literature DB >> 24332517

Anti-PD1 antibody: a new approach to treatment of lymphomas.

Emmanuel Bachy1, Bertrand Coiffier2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24332517     DOI： 10.1016/S1470-2045(13)70587-4

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  13 in total

Review 1.  How to achieve immune control in chronic hepatitis B?

Authors:  Margo J H van Campenhout; Harry L A Janssen
Journal:  Hepatol Int       Date:  2014-09-06       Impact factor: 6.047

2.  (89)Zr-Oxine Complex PET Cell Imaging in Monitoring Cell-based Therapies.

Authors:  Noriko Sato; Haitao Wu; Kingsley O Asiedu; Lawrence P Szajek; Gary L Griffiths; Peter L Choyke
Journal:  Radiology       Date:  2015-02-20       Impact factor: 11.105

Review 3.  Physiological, Tumor, and Metastatic Niches: Opportunities and Challenges for Targeting the Tumor Microenvironment.

Authors:  Meera Murgai; Amber Giles; Rosandra Kaplan
Journal:  Crit Rev Oncog       Date:  2015

Review 4.  Impaired T-Cell Function in B-Cell Lymphoma: A Direct Consequence of Events at the Immunological Synapse?

Authors:  Marian Nassef Kadry Naguib Roufaiel; James W Wells; Raymond J Steptoe
Journal:  Front Immunol       Date:  2015-06-02       Impact factor: 7.561

5.  Inhibition of mitogen-activated protein kinase pathway can induce upregulation of human leukocyte antigen class I without PD-L1-upregulation in contrast to interferon-γ treatment.

Authors:  Kousaku Mimura; Ley-Fang Kua; Kensuke Shiraishi; Lim Kee Siang; Asim Shabbir; Mayumi Komachi; Yoshiyuki Suzuki; Takashi Nakano; Wei-Peng Yong; Jimmy So; Koji Kono
Journal:  Cancer Sci       Date:  2014-09-29       Impact factor: 6.716

Review 6.  Immune checkpoint inhibitors in clinical trials.

Authors:  Elad Sharon; Howard Streicher; Priscila Goncalves; Helen X Chen
Journal:  Chin J Cancer       Date:  2014-09

7.  Epstein-Barr virus-associated primary nodal T/NK-cell lymphoma shows a distinct molecular signature and copy number changes.

Authors:  Siok-Bian Ng; Tae-Hoon Chung; Seiichi Kato; Shigeo Nakamura; Emiko Takahashi; Young-Hyeh Ko; Joseph D Khoury; C Cameron Yin; Richie Soong; Anand D Jeyasekharan; Michal Marek Hoppe; Viknesvaran Selvarajan; Soo-Yong Tan; Soon-Thye Lim; Choon-Kiat Ong; Maarja-Liisa Nairismägi; Priyanka Maheshwari; Shoa-Nian Choo; Shuangyi Fan; Chi-Kuen Lee; Shih-Sung Chuang; Wee-Joo Chng
Journal:  Haematologica       Date:  2017-11-02       Impact factor: 9.941

8.  PD-L1 expression is mainly regulated by interferon gamma associated with JAK-STAT pathway in gastric cancer.

Authors:  Kousaku Mimura; Jun Liang Teh; Hirokazu Okayama; Kensuke Shiraishi; Ley-Fang Kua; Vivien Koh; Duane T Smoot; Hassan Ashktorab; Takahiro Oike; Yoshiyuki Suzuki; Zul Fazreen; Bernadette R Asuncion; Asim Shabbir; Wei-Peng Yong; Jimmy So; Richie Soong; Koji Kono
Journal:  Cancer Sci       Date:  2017-11-18       Impact factor: 6.716

Review 9.  Current status of cancer immunotherapy.

Authors:  K Kono
Journal:  J Stem Cells Regen Med       Date:  2014-04-30

10.  Expression of programmed death ligand-1 and programmed death-1 in samples of invasive ductal carcinoma of the breast and its correlation with prognosis.

Authors:  Tingting Zhou; Di Xu; Bufu Tang; Yanling Ren; Yiru Han; Gege Liang; Jing Wang; Ling Wang
Journal:  Anticancer Drugs       Date:  2018-10       Impact factor: 2.248
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.